Serum tumor markers for detection of hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Serum tumor markers for detection of hepatocellular carcinoma.

Serum tumor markers for detection of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34501851

about

Biomarkers for hepatocellular carcinoma Tumor markers for hepatocellular carcinoma (Review)Hepatocellular carcinoma: Review of disease and tumor biomarkers Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation Biology of hepatocellular carcinoma Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study.Diagnosis of hepatocellular carcinoma.Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma.Present and future possibilities for early diagnosis of hepatocellular carcinoma Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population.Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy A review on laboratory liver function tests.Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma.Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma.V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation.Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.Vascular architecture: is it a helpful histopathological biomarker for hepatocellular carcinoma?Relevance of serum levels of interleukin-6 and syndecan-1 in patients with hepatocellular carcinoma Clinical significance of serum angiocidin levels in hepatocellular carcinoma.Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.Circulating tumor cells measurements in hepatocellular carcinoma.Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.Clinical implication of elevated human cervical cancer oncogene-1 expression in esophageal squamous cell carcinoma.Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.Hepatocellular carcinoma: management of an increasingly common problem Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients.Biomarkers, regerons, and pathways to lethal cancer.Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: expression frequency and their correlation with clinical parameters.Characterization of disease-associated N-linked glycoproteins Assessment of blood flow in hepatocellular carcinoma: correlations of computed tomography perfusion imaging and circulating angiogenic factors Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients.Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.

P2860

Q21285158-93AF58D4-960F-4BBD-B2B0-C2F7AB86444B Q24608195-933C973E-04C2-4D5C-BF07-487CA998F5BC Q26750796-3DDFFD6C-51E1-49A1-92AF-C0ABDC0D35F5 Q26772329-3E2FF93F-C818-4C4F-8A37-A69C8F7C4B53 Q28266656-300C89F6-2825-4F96-9EA3-3E204DCC97F8 Q30360305-981837B2-3675-4BAE-810A-B5823A5B5C05 Q30490554-0270F7E9-83A0-4C3F-8BA8-D5B801E740D5 Q33491067-68F7F47B-61C7-4AE1-A237-4FCF061FB73F Q33612167-F9E59999-2E6B-40A0-95EB-68C01A018D59 Q33911829-F3347C24-745E-44F4-B1F6-33D0DE1379B8 Q33935625-D317A57E-B786-4329-A38A-4B48E4269D44 Q34073054-0696B34D-D8B7-4CA5-AC2A-912728D6B37F Q34256150-3F1301B6-49FB-4B33-8E62-3B2699A2E362 Q34321014-196181C1-8F8F-479B-A482-4B46F99CE346 Q34657401-651966F5-3479-435D-8B32-F13E0A103812 Q34721561-03485A6C-104C-4735-9766-45E9AA30CC1B Q34733478-87CEB825-A2A8-4388-A29A-C581044BEAF7 Q35097226-4DACCD13-239B-4A21-B631-33589239690C Q35379075-2958F95D-F7FC-41B5-BBEC-B10F56FFAAA9 Q35507576-83A22529-0D88-4E62-9C78-F98B1D21AD73 Q35613285-9BC463C8-D0AF-4A9F-BD61-CE07BDDC79F8 Q35629299-F9F75EA4-595B-4E7A-8D2A-403E021F47C9 Q35633563-94999DAA-AB6E-4810-A761-AAF9E1084CCE Q35722843-D1086BE7-1ED0-41A3-A090-DFD130698422 Q35801303-27CD7155-FEBE-40EB-B345-AC4C7FF92CFA Q35956698-C4EEA62E-EF3C-4A62-877C-50C1AC822514 Q35975965-91D96BF5-4D8E-4572-BB87-B0050A1EEBF1 Q36011412-EA007398-2CED-4935-9D48-D6F8918BB57E Q36083213-C7119C77-EB93-4E84-9370-BAB93B351402 Q36285854-CBB18F38-6ACF-49DE-8E90-08543AE88017 Q36598885-0E958544-8EAF-4FEC-9A39-603583D89FEA Q36734983-37291D6B-0F7C-44EC-8930-05D3CC3EE5C1 Q36746503-0987C8E9-8050-4C89-9E70-2B2CCB2DF4C4 Q36961950-539288C8-0DEE-4344-A48D-FFE4F71B7CF0 Q36980454-C3D96B11-E82B-4ECD-ACA5-EA84D497A5DD Q37054571-E17E8A9A-3EA0-4620-A7FA-13DD626BAEBB Q37069869-293E7C30-CA5D-4964-8872-3C2598D3E9A2 Q37225055-9CABD203-5A51-409B-AD0C-8EFAE6BF6002 Q37300543-AFDC5F1D-8E6F-45F7-8CD7-3624DECFC794 Q37477526-59E4ECA6-F5DA-4EA4-ADF4-D47FEF91C80F

P2860

Serum tumor markers for detection of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34501851

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Serum tumor markers for detection of hepatocellular carcinoma.

@ast

Serum tumor markers for detection of hepatocellular carcinoma.

@en

Serum tumor markers for detection of hepatocellular carcinoma.

@nl

type

label

Serum tumor markers for detection of hepatocellular carcinoma.

@ast

Serum tumor markers for detection of hepatocellular carcinoma.

@en

Serum tumor markers for detection of hepatocellular carcinoma.

@nl

prefLabel

Serum tumor markers for detection of hepatocellular carcinoma.

@ast

Serum tumor markers for detection of hepatocellular carcinoma.

@en

Serum tumor markers for detection of hepatocellular carcinoma.

@nl

P1433

Q34501851-566234E3-A08F-4B5F-BE48-B582FC6A3629

P1476

Q34501851-C57E8000-B620-4F89-8F90-23761E2B3A87

P2093

Q34501851-15CAD5E5-C52A-4950-8C6F-67BFF81B0437

Q34501851-5FB4A2A6-FDB0-41A4-8D10-8F0525FF5257

Q34501851-77DE592B-A1A6-4210-8A97-6E68478AE941

P2860

Q34501851-04E86A3F-9A60-4656-893E-15E0127F61B8

Q34501851-102598A7-7CAC-47CD-95C0-3B77B64B34EC

Q34501851-1202DCAB-7ED1-4B08-B98D-69F35CF8FA79

Q34501851-1222667E-E521-421A-B52E-E8A95F89CCB6

Q34501851-16752822-8425-45AD-BBFB-8FD019F102B2

Q34501851-190B498E-D81E-4D8E-AA7F-07C706A7E5C5

Q34501851-19EC40EC-759D-4A8C-8A9B-E0FCFA0CCBF3

Q34501851-26D4DAE5-6251-4269-8480-A6FFDFC34898

Q34501851-2B0ABA65-27EE-4707-92C1-4D9930492769

Q34501851-36C23CA5-2315-4612-929C-B51D344D8659

P304

Q34501851-DFCC905B-9588-4560-8D69-8328AEFA5D7A

P31

Q34501851-C071BF11-B6BA-4E64-B963-33DDB0C17E12

P356

Q34501851-B2FB1CA8-C38D-4116-ADBA-ECFC5C78FDEB

P407

Q34501851-CC9E4C73-2788-4860-B5F4-0D9A01B8C1F4

P433

Q34501851-91CA7454-4C51-4930-9F3E-FC224ED866C2

P478

Q34501851-2BD4DFF2-599F-4EFA-AE3B-1B5FCD7B2D90

P577

Q34501851-2AEEBB59-21E0-4D52-B00B-CD21A3B968B8

P698

Q34501851-6F011398-D9A4-40F3-94FC-F50ED2CC221B

P932

Q34501851-7DD3BCEC-6154-43CC-956B-C58BBB21B44D

P356

WJG.V12.I8.1175

P1433

World Journal of Gastroenterology

P1476

Serum tumor markers for detection of hepatocellular carcinoma.

@en

P2093

Feng Luo

http://www.w3.org/2001/XMLSchema#string

Jia Liu

http://www.w3.org/2001/XMLSchema#string

Lin Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.

From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels.

The mechanisms of angiogenesis in hepatocellular carcinoma: angiogenic switch during tumor progression.

Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.

P304

1175-1181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V12.I8.1175

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16534867

http://www.w3.org/2001/XMLSchema#string

P932

4124425

http://www.w3.org/2001/XMLSchema#string